Literature DB >> 27942883

Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.

Chikara Yamashita1, Manabu Funayama1,2, Yuanzhe Li1, Hiroyo Yoshino2, Hitoshi Yamada3, Yusuke Seino4, Hiroyuki Tomiyama1, Nobutaka Hattori5,6.   

Abstract

A recessive mutation in PLA2G6, which is known to cause infantile neuroaxonal dystrophy (INAD) and neurodegeneration associated with brain iron accumulation (NBIA), has recently been shown to be responsible for PARK14-linked dystonia-parkinsonism. To study the frequency of PLA2G6 mutations, including those caused by gene rearrangement in patients with parkinsonism, we performed direct sequencing and investigated copy number variations (CNVs) of this gene in 109 Japanese patients with parkinsonism. Direct sequencing revealed a homozygous mutation (c.1495G>A; p.A499T), which is likely to be pathogenic and is already registered as rs141045127, and two compound-heterozygous mutations we have previously reported. No CNVs in PLA2G6 were detected in our subjects. Our results suggest that CNV in PLA2G6 is rare in parkinsonism, at least in the Japanese population, in contrast to the reports of its frequency in INAD. Further large studies in various populations are warranted to elucidate what causes the difference in frequencies of PLA2G6 rearrangement mutations between INAD and dystonia-parkinsonism.

Entities:  

Keywords:  Copy number variation (CNV); PARK14; PLA2G6; Parkinsonism

Mesh:

Substances:

Year:  2016        PMID: 27942883     DOI: 10.1007/s00702-016-1658-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

1.  Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.

Authors:  Monika B Hartig; Konstanze Hörtnagel; Barbara Garavaglia; Giovanna Zorzi; Tomasz Kmiec; Thomas Klopstock; Kevin Rostasy; Marina Svetel; Vladimir S Kostic; Markus Schuelke; Evelyn Botz; Adolf Weindl; Ivana Novakovic; Nardo Nardocci; Holger Prokisch; Thomas Meitinger
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

2.  Multiplex ligation-dependent probe amplification (MLPA) analysis is an effective tool for the detection of novel intragenic PLA2G6 mutations: implications for molecular diagnosis.

Authors:  Danielle Crompton; Pauline K Rehal; Lesley MacPherson; Katharine Foster; Peter Lunt; Imelda Hughes; Angela F Brady; Michael G Pike; Susanna De Gressi; Neil V Morgan; Carol Hardy; Matthew Smith; Fiona MacDonald; Eamonn R Maher; Manju A Kurian
Journal:  Mol Genet Metab       Date:  2010-02-16       Impact factor: 4.797

Review 3.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

Review 4.  Complicated recessive dystonia parkinsonism syndromes.

Authors:  Susanne A Schneider; Kailash P Bhatia; John Hardy
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

5.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

6.  Neurodegeneration associated with genetic defects in phospholipase A(2).

Authors:  A Gregory; S K Westaway; I E Holm; P T Kotzbauer; P Hogarth; S Sonek; J C Coryell; T M Nguyen; N Nardocci; G Zorzi; D Rodriguez; I Desguerre; E Bertini; A Simonati; B Levinson; C Dias; C Barbot; I Carrilho; M Santos; I Malik; J Gitschier; S J Hayflick
Journal:  Neurology       Date:  2008-09-17       Impact factor: 9.910

7.  Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Authors:  Ya-Xing Gui; Zhong-Ping Xu; Hong-Mei Liu; Jin-Jia Zhao; Xing-Yue Hu
Journal:  Parkinsonism Relat Disord       Date:  2012-11-20       Impact factor: 4.891

8.  Primer3--new capabilities and interfaces.

Authors:  Andreas Untergasser; Ioana Cutcutache; Triinu Koressaar; Jian Ye; Brant C Faircloth; Maido Remm; Steven G Rozen
Journal:  Nucleic Acids Res       Date:  2012-06-22       Impact factor: 16.971

9.  Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines.

Authors:  Guy J Leclerc; Gilles M Leclerc; Julio C Barredo
Journal:  Cancer Cell Int       Date:  2002-03-07       Impact factor: 5.722

10.  New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations.

Authors:  Mustafa A Salih; Emeline Mundwiller; Arif O Khan; Abdulmajeed AlDrees; Salah A Elmalik; Hamdy H Hassan; Mohammed Al-Owain; Hisham M S Alkhalidi; Istvan Katona; Mohammad M Kabiraj; Roman Chrast; Amal Y Kentab; Hamad Alzaidan; Richard J Rodenburg; Thomas M Bosley; Joachim Weis; Michel Koenig; Giovanni Stevanin; Hamid Azzedine
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more
  2 in total

1.  Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review.

Authors:  Ting Shen; Jing Hu; Yasi Jiang; Shuai Zhao; Caixiu Lin; Xinzhen Yin; Yaping Yan; Jiali Pu; Hsin-Yi Lai; Baorong Zhang
Journal:  Front Neurol       Date:  2019-08-21       Impact factor: 4.003

2.  Non-Motor Symptoms in PLA2G6-Associated Dystonia-Parkinsonism: A Case Report and Literature Review.

Authors:  Lydia Vela-Desojo; Daniele Urso; Mireia Osuna-López; Janet Hoenicka
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.